NRG
42
5
RRC
60
2
PEP
29
-3
SRE
18
-19
ED
42
-3
RF
44
-4
USB
50
-3
YUM
30
-4
AIV
46
3
PFG
27
-7
PVH
40
-8
EMR
54
-3
PG
32
-6
NWS
62
-2
XRAY
23
-5
ADI
55
-7
TEL
50
-5
DUK
55
-4
MA
44
-2
AMAT
44
-4
NRG
42
5
RRC
60
2
PEP
29
-3
SRE
18
-19
ED
42
-3
RF
44
-4
USB
50
-3
YUM
30
-4
AIV
46
3
PFG
27
-7
PVH
40
-8
EMR
54
-3
PG
32
-6
NWS
62
-2
XRAY
23
-5
ADI
55
-7
TEL
50
-5
DUK
55
-4
MA
44
-2
AMAT
44
-4
Financhill
Back

Spyre Therapeutics Stock Predictions

Unlock the power of "two-minute trades"

Learn how today!
Sell
19

SYRE
Spyre Therapeutics

Last Price:
$22.45
Seasonality Move:
13.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings

Analyze Any Stock Free

Spyre Therapeutics Stock Forecast

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 4.6% based on the past 8 years of stock performance.
  • Spyre Therapeutics has risen higher in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Spyre Therapeutics Stock Undervalued?
    The current Spyre Therapeutics [SYRE] share price is $22.46. The Score for SYRE is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Spyre Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 4.6% based on the past 8 years of stock performance.

Spyre Therapeutics Stock Rating

Sell
19
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics overpriced?

  • Spyre Therapeutics has risen higher in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Spyre Therapeutics Stock Price History

Is SYRE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
spyre.com

52-Week Data

52-Week High:
47.97
52-Week Low:
20.07

Prediction Charts

Market Cap:
1.3B
Price in USD:
22.46
Volume:
686.8K
Beta:
2.49

Technical Analysis

SMA50:
28.11
SMA100:
28.66
SMA200:
30.20
52-Wk Change:
1.49%

Stock Predictions

  • Is Spyre Therapeutics stock public?
    Yes, Spyre Therapeutics is a publicly traded company.
  • What is the Spyre Therapeutics stock quote today?
    The Spyre Therapeutics stock price is 22.46 USD today.
  • How to buy Spyre Therapeutics stock online?
    You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-19 23.56 23.13 23.86 22.59
Dec-20 22.90 23.89 24.88 22.62
Dec-23 23.74 23.59 23.85 22.79
Dec-24 23.58 23.34 23.64 22.73
Dec-26 23.13 24.07 24.08 22.95
Dec-27 24.00 23.67 24.34 23.18
Dec-30 23.35 22.54 23.44 22.37
Dec-31 22.85 23.28 24.05 22.63
Jan-2 23.60 23.85 24.45 23.33
Jan-3 23.66 24.35 24.83 23.66
Jan-6 24.66 24.42 25.40 24.25
Jan-7 24.60 24.35 26.01 24.05
Jan-8 24.21 24.02 24.52 23.77
Jan-10 23.29 22.46 23.76 21.60

Spyre Therapeutics Earnings

Spyre Therapeutics Earnings Report: Per Share Spyre Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Spyre Therapeutics Forecast Revenue Growth

Spyre Therapeutics Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $1.10 per share.

* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.